Abstract
Objective
To determine and explain the effect of age on exhaled nitric oxide values in North African healthy subjects aged from 5 to 83 years.
Design
Prospective cross-sectional study.
Methods
Volunteer children adults and elderly healthy subjects were included. A medical questionnaire was used to assess several subject characteristics. The levels of exhaled fraction of nitric oxide (FeNO) were measured by Medisoft HypAir FeNO method. Spirometry function test was done after the FeNO measurement. The following parameters were measured: forced vital capacity (FVC, L); 1st second forced expiratory volume (FEV1, L); FEV1/FVC ratio (absolute value); maximal mid expiratory flow (MMEF, L/s); Mid expiratory flow from 25 to 75% (MEF25%, MEF50%, and MEF75%). Statistical analyses were carried out using Statistica software with a significance set at the 0.05 level.
Results
A significant increase in FeNO is noted between groups with respective age ranges of (5, 17) and (17, 25) years with a breakpoint at 1,397,034 years. A significant decrease of FeNO is noted between groups with respective age ranges of (45, 55) and (55, 65) years with a breakpoint at 6,366,052 years. No statistical significant difference was found between females’ and males’ means FeNO data. Finally, SEL, obesity status, and hypertension contribute significantly in the variations of FeNO values.
Conclusion
The development and aging of the lung touched non-respiratory functions and so modified FeNO values in healthy North African subjects.
Similar content being viewed by others
References
Taylor DR (2006) Nitric oxide as a clinical guide for asthma management. J Allergy Clin Immunol 117(2):259–262
Bateman ED, Hurd SS, Barnes PJ, Bousquet J, Drazen JM, FitzGerald M et al (2008) Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 31(1):143–178
Olin A-C, Rosengren A, Thelle DS, Lissner L, Bake B, Torén K (2006) Height, age, and atopy are associated with fraction of exhaled nitric oxide in a large adult general population sample. Chest 130(5):1319–1325
Kovesi T, Kulka R, Dales R (2008) Exhaled nitric oxide concentration is affected by age, height, and race in healthy 9- to 12-year-old children. Chest 133(1):169–175
Olivieri M, Talamini G, Corradi M, Perbellini L, Mutti A, Tantucci C et al (2006) Reference values for exhaled nitric oxide (reveno) study. Respir Res 7:94
Dressel H, de la Motte D, Reichert J, Ochmann U, Petru R, Angerer P et al (2008) Exhaled nitric oxide: independent effects of atopy, smoking, respiratory tract infection, gender and height. Respir Med 102(7):962–969
Travers J, Marsh S, Aldington S, Williams M, Shirtcliffe P, Pritchard A et al (2007) Reference ranges for exhaled nitric oxide derived from a random community survey of adults. Am J Respir Crit Care Med 176(3):238–242
Kim S-H, Kim TH, Sohn JW, Yoon HJ, Shin DH, Park SS (2010) Reference values and determinants of exhaled nitric oxide in healthy Korean adults. J Asthma Off J Assoc Care Asthma 47(5):563–567
Rouatbi S, Alqodwa A, Ben Mdella S, Ben Saad H (2013) Fraction of exhaled nitric oxide (FeNO) norms in healthy North African children 5–16 years old. Pediatr Pulmonol 48(10):981–995
Rouatbi S, Chouchene MA, Sfaxi I, Rejeb MB, Tabka Z, Saad HB (2014) Fraction of exhaled nitric oxide (FeNO) norms in healthy Tunisian adults. BioMed Res Int 2014:269670
Sfaxi I, Saad HB, Rouatbi S (2015) Fraction of exhaled nitric oxide in healthy elderly Tunisian subjects. Nitric Oxide 50:88–97
Solaligue DES, Rodríguez-Castillo JA, Ahlbrecht K, Morty RE (2017) Recent advances in our understanding of the mechanisms of late lung development and bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 313(6):L1101–L1153
Schittny JC (2017) Development of the lung. Cell Tissue Res 367(3):427–444
Schmiedl A, Roolfs T, Tutdibi E, Gortner L, Monz D (2017) Influence of prenatal hypoxia and postnatal hyperoxia on morphologic lung maturation in mice. PloS ONE 12(4):e0175804
Morbidelli L, Chang CH, Douglas JG, Granger HJ, Ledda F, Ziche M (1996) Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 270:H411–H415
Ziche M, Morbidelli L, Choudhuri R, Zhang HT, Donnini S, Granger HJ, Bicknell R (1997) Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest 99:2625–2634
The Official Workshop Report (2004) Mechanisms and limits of induced postnatal lung growth. Am J Respir Crit Care Med 170:319–343
Rouatbi S, Dardouri K, Farhat Ouahchi Y, Mdella SB, Tabka Z, Guenard H (2006) Aging of the lung parenchyma. Rev Mal Respir 23(5 Pt 1):445–452
Guénard H, Rouatbi S (2004) Physiological aspects of the decline of pulmonary function with age. Rev Mal Respir 21(5 Pt 3):8S13–8S24
Ferris BG (1978) Epidemiology standardization project (American Thoracic Society). Am Rev Respir Dis 118(6 Pt 2):1–120
Obesity (2000) preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894:1–253
American Thoracic Society, European Respiratory Society (2005) ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171(8):912–930
Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R et al (2005) Interpretative strategies for lung function tests. Eur Respir J 26(5):948–968
Tabka Z, Hassayoune H, Guenard H, Zebidi A, Commenges D, Essabah H et al (1995) Spirometric reference values in a Tunisian population. Tunis Méd 73(2):125–131
Olin A-C, Bake B, Torén K (2007) Fraction of exhaled nitric oxide at 50 mL/s: reference values for adult lifelong never-smokers. Chest 131(6):1852–1856
Habib SS, Abba AA, Al-Zoghaibi MA, Subhan MM (2009) Reference range values of fractional exhaled nitric oxide in healthy Arab adult males. Saudi Med J 30(11):1395–1400
Gelb AF, George SC, Camacho F, Fraser C, Taylor CF, Shakkottai S (2011) Increased nitric oxide concentrations in the small airway of older normal subjects. Chest 139(2):368–375
Jo E-J, Song W-J, Kim T-W, Park H-W, Chang Y-S, Kim T-B et al (2014) Reference ranges and determinant factors for exhaled nitric oxide in a healthy korean elderly population. Allergy Asthma Immunol Res 6(6):504–510
Matsunaga K, Hirano T, Kawayama T, Tsuburai T, Nagase H, Aizawa H, Akiyama K, Ohta K, Ichinose M (2010) Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 59(4):363–367
Högman M, Thornadtsson A, Liv P, Hua-Huy T, Dinh-Xuan AT, Tufvesson E, Dressel H, Janson C, Koskela K, Oksa P, Sauni R, Uitti J, Moilanen E, Lehtimäki L (2017) Effects of growth and aging on the reference values of pulmonary nitric oxide dynamics in healthy subjects. J Breath Res 11(4):047103
Chen E, Strunk RC, Bacharier LB, Chan M, Miller GE (2010) Socioeconomic status associated with exhaled nitric oxide responses to acute stress in children with asthma. Brain Behav Immun 24(3):444–450
Leng B, Jin Y, Li G, Chen L, Jin N (2015) Socioeconomic status and hypertension: a meta-analysis. J Hypertens 33(2):221–229
Ciprandi G, Schiavetti I, Fontana RB, Sorbello V, Ricciardolo FL (2014) Overweight and obesity as risk factors for impaired lung function in patients with asthma: a real-life experience. Allergy Asthma Proc 35(4):e62–e71
Kim SH, Kim TH, Lee JS, Koo TY, Lee CB, Yoon HJ, Shin DH, Park SS, Sohn JW (2011) Adiposity, adipokines, and exhaled nitric oxide in healthy adults without asthma. J Asthma 48(2):177–182
Dweik RA, Boggs PB, Erzurum SC, Irvin CG, Leigh MW, Lundberg JO, Olin A-C, Plummer AL, Taylor DR (2011) An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FeNO) for clinical applications. Am J Respir Crit Care Med 184(5):602–615
Travers J, Marsh S, Aldington S et al (2006) Reference values for exhaled nitric oxide (REVENO) study. Respir Res 7:94.
Jacinto T, Malinovschi A, Janson C, Fonseca J and Alving K (2015) Evolution of exhaled nitric oxide levels throughout development and aging of healthy humans. J Breath Res 9(3):036005
Bentayeb M, Billionnet C, Baiz N, Derbez M, Kirchner S, Annesi-Maesano I (2013) Higher prevalence of breathlessness in elderly exposed to indoor aldehydes and VOCs in a representative sample of French dwellings. Respir Med 107(10):1598–1607
Khansari N, Shakiba Y, Mahmoudi M. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 2009;3(1):73–80
Malerba M, Damiani G, Carpagnano GE, Olivini A, Radaeli A, Ragnoli B, Foschino MP, Olivieri M (2016) Values in elderly people for exhaled nitric oxide study. Rejuvenation Res 19(3):233–238
Acknowledgements
The authors thank Ines Sfaxi, Ashraf Alquodwa, Mohamed Ali Chouchene, and all the subjects who participated in the present study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflicts of interest concerning this article.
Rights and permissions
About this article
Cite this article
Rouatbi, S., Ghannouchi, I. & Bensaad, H. The Effects of Aging on Exhaled Nitric Oxide (FeNO) in a North African Population. Lung 197, 73–80 (2019). https://doi.org/10.1007/s00408-018-0188-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00408-018-0188-5